DeepIntent Survived the DSP Winter - Then Taught Pharma Ads to Count Prescriptions, Not Clicks

The New York ad-tech company nearly ran out of road when venture funding for new DSPs froze. A decade later, it sells pharma marketers something the open web rarely offers: a way to connect media spend with clinical outcomes.